Individual Versus Group Exposure With Response Prevention (ERP) for the Treatment of Obsessive Compulsive Disorder (OCD)

NCT03926546 | Withdrawn

• 1 other identifier: H-44611
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

The primary objective is to examine the efficacy of implementing evidence based Exposure and Response Prevention (ERP) within group therapy versus individual therapy by monitoring reduction of Obsessive-Compulsive Disorder (OCD) symptomology.

Conditions

OCD

Outcome Measures

Primary Outcomes (1)

• Yale-Brown Obsessive-Compulsive Scale

  Participant OCD severity is measured with Yale-Brown Obsessive-Compulsive Scale over the course of their time in the study. Severity is measured at baseline (week 1), mid (week 3), and post (week 6) participation in ERP over the course of 6 weeks. Severity on the scale is measured based on a score range of 0-40. Participants with scores of 0-13 are considered to have mild symptoms. Scores of 14-25 are considered moderate. 26-34 are considered to be moderate-severe. 35-40 are considered to be very severe.

  Post-treatment, 6 weeks after baseline

Study Arms (2)

Individual ERP

EXPERIMENTAL

Individual Exposure and Response Prevention for OCD

Behavioral: ERP for Individuals

Group ERP

EXPERIMENTAL

Group Exposure and Response Prevention for OCD

Behavioral: ERP for Individuals

Interventions

ERP for Individuals BEHAVIORAL

Comparing Group vs. Individual ERP for OCD

Also known as: ERP for Groups

Group ERP; Individual ERP

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants must be adults 18 years or older.
• Participants must have the capacity and ability to give informed consent.
• Participants have been given an assessment and received a diagnosis of OCD.
• Participants must speak English.
• Participants must be able to physically attend treatment.

You may not qualify if:

• Prisoners or any other high-risk population group.
• experiencing active psychosis
• experiencing active substance abuse disorder
• experiencing active suicidality

Sponsors & Collaborators

• Baylor College of Medicine: lead

Study Sites (1)

Baylor College of Medicine Jamail Building

Houston, Texas, 77030, United States

Location

MeSH Terms

Interventions

Population Groups

Intervention Hierarchy (Ancestors)

Demography; Population Characteristics

Study Officials

• Elizabeth McIngvale, Ph.D.

  Baylor College of Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: FACTORIAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor, Psychiatry Research

Study Record Dates

• First Submitted: January 9, 2019
• First Posted: April 24, 2019
• Study Start: May 1, 2020
• Primary Completion: December 1, 2020
• Study Completion: February 1, 2021
• Last Updated: May 27, 2020

Record last verified: 2020-05

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)